ReviewAging clinical and experimental research2026
External validation of geriatric influenza death score: a prospective validation study.
Review in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction of an auxiliary diagnostic model for secondary pulmonary bacterial infection in influenza based on routine detection indicators.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe global challenge of population aging continues to intensify. Current estimates project that by 2050, the world's population will approach 10 billion, with elderly people comprising an estimated 1.6 billion individuals. Due to age-related immunosenescence, older adults face a significantly elevated risk of serious influenza complications compared to younger individuals. During influenza epidemic seasons, determining the appropriate disposition (discharge, hospital admission or Intensive Care Unit admission) of elderly patients with influenza presents a significant challenge. In 2018, Chung et al. developed the Geriatric Influenza Death (GID) score as a potential clinical decision rule to aid clinical decision-making for older adults with influenza. We conducted this study to externally validate the GID score. METHOD AND MATERIALS: In this prospective cohort study geriatric patients (aged ≥ 65 years) presenting to the Emergency Department (ED) between September 2023 and March 2024 with fever, cough, and a positive influenza test were enrolled using convenience sampling. Patients were excluded if they left against medical advice or lacked sufficient data for scoring. The GID score was calculated for each patient using clinical and laboratory data: severe coma (2 scores), history of cancer or coronary artery disease, elevated C-Reactive Protein, bandemia (1 score each). Based on the GID score, patients were categorized into low (0-1), medium [2], or high-risk (≥ 3) groups. The primary outcome was 30-day all-cause mortality. Performance of the score was assessed using the area under the receiver operating characteristic curve (AUC).
resultsOf 378 patients screened, 120 met inclusion criteria. Thirty-day mortality rates increased with the GID score: 15.9% for score 1, 41.7%% for score 2, and 44.4% for score 3. When used for predicting mortality, the GID score with a threshold of ≥ 2 demonstrated moderate performance with an AUC of 0.66 (95% Confidence Interval: 0.53-0.83) and sensitivity and specificity of 70.6% and 61.6%, respectively.
conclusionIn summary, the GID score offers a practical and efficient method for predicting 30-day mortality and informing disposition decisions for older ED patients with influenza.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.